2017 annual report
letter to our shareholders
company highlights
consolidated statement of operations
driving commercial adoption
expanding reimbursement
Nikki Woolfolk, Optune user
Matt Lozano, Senior Device Support Specialist
advancing our clinical pipeline
we can leverage physics to fight cancer
Ori Farber, Senior Medical Manager
Professor Ignace Vergote, clinical trial investigator
building long-term shareholder value
positioned for future growth
significant unmet medical need
Tomoe Kamata, Special Project Manager
Pritesh Shah, Senior Vice President of the Americas
Novocure leadership
downloads
downloads
Downloads
Format
Size
Novocure Proxy Statement
PDF
690 KB
Novocure 2017 10-K
PDF
1.5 MB
Novocure 2017 Annual Report
PDF
5.5 MB